Literature DB >> 35571225

Detergent-Free Functionalization of Hybrid Vesicles with Membrane Proteins Using SMALPs.

Rosa Catania1,2, Jonathan Machin1,2, Michael Rappolt3, Stephen P Muench1,2, Paul A Beales1,4, Lars J C Jeuken1,2,5.   

Abstract

Hybrid vesicles (HVs) that consist of mixtures of block copolymers and lipids are robust biomimetics of liposomes, providing a valuable building block in bionanotechnology, catalysis, and synthetic biology. However, functionalization of HVs with membrane proteins remains laborious and expensive, creating a significant current challenge in the field. Here, using a new approach of extraction with styrene-maleic acid (SMA), we show that a membrane protein (cytochrome bo 3) directly transfers into HVs with an efficiency of 73.9 ± 13.5% without the requirement of detergent, long incubation times, or mechanical disruption. Direct transfer of membrane proteins using this approach was not possible into liposomes, suggesting that HVs are more amenable than liposomes to membrane protein incorporation from a SMA lipid particle system. Finally, we show that this transfer method is not limited to cytochrome bo 3 and can also be performed with complex membrane protein mixtures.
© 2022 The Authors. Published by American Chemical Society.

Entities:  

Year:  2022        PMID: 35571225      PMCID: PMC9097535          DOI: 10.1021/acs.macromol.2c00326

Source DB:  PubMed          Journal:  Macromolecules        ISSN: 0024-9297            Impact factor:   6.057


Introduction

Vesicles made of natural or synthetic lipids (liposomes) are a suitable platform for mimicking membrane structures and functions found in nature.[1,2] Liposomes have been widely exploited to fabricate artificial compartments in bottom-up synthetic biology (artificial cells and organelles) and nanoreactors in compartmentalized (photo)catalysis.[3,4] Functionalization of liposomes in biotechnology is achieved by the reconstitution of membrane proteins (MPs), which in spite of their complex amphiphilic nature, have an increasing number of promising applications in areas such as drug discovery,[5] vaccines,[6] biosensors,[7] and energy conversion.[8] However, the application of proteoliposomes is still hampered by the lack of chemical and physical long-term stability (typically days)[9] and the complexity of purification and reconstitution of MPs.[10,11] Recent developments using amphiphilic polymers have shown promise in solving these experimental limitations. Amphiphilic polymers can self-assemble into robust and stable vesicles, known as polymersomes.[12,13] Despite the advantageous stability and tunability of these synthetic vesicles,[14] the non-native polymeric environment can limit the functional incorporation of many MPs.[15] Hybrid vesicles (HVs), composed of a mixture of block copolymers and lipids, have proven to be a balanced compromise between liposome biocompatibility and polymersome stability.[16−20] Several block copolymers have been studied to correlate how their chemical structure affects the overall properties of the HVs, and both well-mixed and phase-separated membranes have been used.[15,21,22] We have previously shown that the membrane protein cytochrome bo3 (cyt bo3) can be functionally reconstituted into HVs containing up to 50 mol % of the diblock copolymer poly(butadiene-b-ethylene oxide) (PBd22-b-PEO14) with POPC lipids, with minimal loss in protein activity and enhanced lifetime up to 500 days.[16,23] Despite the promise of polymersomes and HVs, the process of extraction, purification, and functional reconstitution of MPs still presents major challenges. Reconstitution methods into polymersomes and HVs are based on methods developed for reconstitution in liposomes, which require detergents and often extensive optimization. Detergents can destabilize MPs by inducing protein unfolding, dissociation of small subunits, and removal of natural lipids associated with the protein hydrophobic regions, and consequently compromise their activity and limit their functional lifetime.[24−26] Thus, the selection of a compatible detergent and optimum condition to extract a target protein can be a laborious, time-consuming, and risk-prone procedure.[27,28] Here, we report a novel strategy for the reconstitution of a membrane protein, cyt bo3, from Escherichia coli (Figure A), into HVs. Cyt bo3 is a four-subunit membrane enzyme complex (∼143 kDa) from E. coli that belongs to the heme-copper oxidase enzyme family and, as such, accepts electrons from ubiquinol and passes them onto molecular oxygen, coupling the electron transfer with proton pumping across the membrane (Figure A).[29] Activity of cyt bo3, and thus functional reconstitution into the membrane vesicles, is commonly evaluated by measuring oxygen consumption. For the HVs, we selected PBd22-b-PEO14 (MW 1.8 kDa) (Figure B), as this copolymer is a compromise between the stability of higher MW polymers and minimizing the difference in hydrophobic thickness between the membranes of pure polymer and pure lipid systems and forms a homogeneous blend with lipids.[15,30]
Figure 1

(A) Schematic representation of the structure and function of cyt bo3 (orange) embedded in the lipid bilayer (represented with yellow lipid tails and blue head groups). (B) Chemical structures of PBd22-b-PEO14 copolymer, with the polybutadiene block polymer in red and the polyethylene glycol block polymer in green. (C) SMA (2:1) copolymer, with the styrene group in red and the maleic acid group in blue.

(A) Schematic representation of the structure and function of cyt bo3 (orange) embedded in the lipid bilayer (represented with yellow lipid tails and blue head groups). (B) Chemical structures of PBd22-b-PEO14 copolymer, with the polybutadiene block polymer in red and the polyethylene glycol block polymer in green. (C) SMA (2:1) copolymer, with the styrene group in red and the maleic acid group in blue. Using a novel procedure, we show that reconstitution of cyt bo3 into HVs does not require the use of a detergent. Instead, insertion of cyt bo3 into the HVs is accomplished by a second amphiphilic polymer, styrene-maleic acid copolymer (SMA, Figure C). SMA and similar polymers have emerged as an effective material to extract and solubilize MPs, including cyt bo3,[31] while preserving protein activity,[32] overcoming issues encountered with detergent-mediated solubilization.[33,34] SMA is an anionic copolymer containing carboxylic acid pendant groups in the form of maleic acid alternating with the hydrophobic styrene pendant groups (Figure C). Unlike detergents, SMA copolymers do not self-assemble into micelles.[35] When added to cellular membrane extracts, the hydrophobic styrene groups of SMA copolymers intercalate between the acyl chains of the lipid bilayer, whereas the hydrophilic maleic acid groups interface with the solvent.[32] This interaction between SMA copolymers and membranes leads to the spontaneous formation of discoidal particles of ∼10 nm diameter.[36] SMA copolymers offer the advantage of solubilizing MPs directly from the cell membrane by forming these nanodisc structures, called SMA–lipid particles (SMALPs), which retain the natural lipids associated with the MPs.[37,38] MPs can be purified from SMALPs by affinity chromatography.[39] Besides their use for structural and functional studies,[39] SMALPs have recently been shown to mediate reconstitution of MPs into planar lipid bilayers, as the tetrameric K+ channel,[40] and into liposomes, as exemplified for a cytochrome c oxidase[41] and a Na+/H+ antiporter.[42] In addition to SMA, other maleic acid copolymers capable of solubilizing MPs have been synthesized with various chemical functionalities, such as aliphatic side chains replacing the styrene group[43−45] or differently charged moieties in the maleic group, providing a diverse toolkit of potential polymers.[45−47]

Results

First, we investigated the stability of HVs when exposed to increasing concentrations of SMA copolymer (Figures S2 and S3). SMA is seen to solubilize HVs at an SMA to lipid and PBd22-b-PEO14 copolymer ratio of 1 (molSMA/mol(Lipids+PBd22-), with less SMA needed to solubilize HVs than liposomes. Still, the amount of SMA required to reconstitute cyt bo3 is about 20 time less (see below), and thus we excluded that the presence of SMA during the reconstitution of cyt bo3 could affect the stability of the hybrid vesicles. SMA-solubilized cyt bo3 (SMAcyt ) were prepared from membrane extracts of E. coli GO105/pJRhisA[48] (protein content ∼4 mg/mL), containing His-tagged cyt bo3, by incubation with 2% (w/v) SMA for 2 h at room temperature (RT) and purified via Ni-NTA affinity chromatography (as described in the Supporting Information). Purity of SMAcyt  was confirmed in a direct comparison with a previous published procedure[48] using n-dodecyl-β-d-maltoside (Figure S1, DDMcyt ). SMAcyt  and DDMcyt  were reconstituted into HVs and lipid-only liposomes (E. coli “polar” lipid extract, LIP). As such, four vesicle samples are compared, which hereafter will be named (1) HV-SMAcyt , (2) HV-DDMcyt , (3) LIP-SMAcyt  and (4) LIP-DDMcyt . HVs were composed of PBd22-b-PEO14 and E. coli “polar” lipid extracts at a 1:1 mol/mol ratio. Reconstitution of DDMcyt  into HV-DDMcyt  and LIP-DDMcyt  was performed by destabilization with detergent (Triton X-100), followed by extensive removal of the detergent by Biobeads, as previously reported[16] (described in the Supporting Information). To reconstitute SMAcyt , we took advantage of SMA precipitating in the presence of MgCl2 (>5 mM) due to the interactions of the divalent cation Mg2+ with the maleic acid groups.[49] Without the SMA belt, the lipid particles become unstable and will precipitate with the contained MP, unless reconstituted. This strategy has previously been used to exchange the membrane protein AcrB from SMALP into an amphipol scaffold.[38] SMAcyt  was incubated with HVs (or liposomes as control) on ice for 30 min at a protein to lipid ratio of ∼1:100 (w/w) and then incubated with 10 mM MgCl2 to precipitate SMA. Cyt bo3 that was not reconstituted into HVs or liposomes was removed by centrifugation at 17000g for 15 min. Treatment with 10 mM MgCl2 does not affect the size of the vesicles (Figure S4). Dynamic light scattering (DLS) analysis of the four reconstituted samples in Figure (see Table S1 for details) showed that the diameter of the HVs (Figure A) slightly increased after SMAcyt  reconstitution (from ∼130 nm to ∼150 nm), but otherwise remain largely unaltered. In contrast, DDMcyt  reconstitution into HV shows a clear reduction in liposome size and an increase in polydispersity (see Table S1). The same is observed for the reconstitution of DDMcyt  in liposomes (Figure B). The decreases in size suggest that the Biobead treatment might extract lipids from the HVs and liposomes. The reason for the increase in polydispersity during the DDM reconstitution is unknown, but we hypothesize that some cyt bo3 might not properly have reconstituted, causing some aggregation in the sample.
Figure 2

Physical characterization of membrane vesicles. Dynamic light scattering (DLS) volume profiles of (A) HVs, HV-SMAcyt , and HV-DDMcyt  and (B) liposomes, LIP-SMAcyt , and LIP-DDMcyt . The concentration of analyzed samples was 0.5 mg/mL of total PBd22-b-PEO14 polymer and lipid components.

Physical characterization of membrane vesicles. Dynamic light scattering (DLS) volume profiles of (A) HVs, HV-SMAcyt , and HV-DDMcyt  and (B) liposomes, LIP-SMAcyt , and LIP-DDMcyt . The concentration of analyzed samples was 0.5 mg/mL of total PBd22-b-PEO14 polymer and lipid components. The reconstitution efficiency of cyt bo3 was quantified by solubilization of the vesicles with Triton X-100 and UV analysis of the Soret peak of cyt bo3 (409 nm). Interestingly, the reconstitution efficiency of SMAcyt3 was profoundly different between HVs and liposomes (Table ). SMAcyt  could be directly reconstituted into HVs but not into liposomes. This difference in reconstitution efficiency between HVs and liposomes was also confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Figure and Figure S5).
Table 1

Reconstitution Efficiency of SMAcyt 3 and DDMcyt 3 in Vesicles As Quantified by UV–Vis Spectroscopy of the Soret Band (409 nm)

vesicle samplereconstitution efficiency (%)±SD
HV-SMAcyt bo373.9±13.5
LIP-SMAcyt bo3not detected 
HV-DDMcyt bo361.0±7.5
LIP-DDMcyt bo358.0±3.5
Figure 3

Analysis of (A) SMAcyt , (B) HV-SMAcyt , and (C) LIP-SMAcyt . After direct incubation of SMAcyt  with HVs or liposomes, samples were incubated with increasing Mg2+ concentration for 2 h, followed by centrifugation at 17000g for 15 min to pellet nonreconstituted SMAcyt . The supernatant containing HVs or liposomes was analyzed with SDS-PAGE (Coomassie Blue staining). Only subunit I of cyt bo3 is shown. The entire gel is shown in Figure S5.

Analysis of (A) SMAcyt , (B) HV-SMAcyt , and (C) LIP-SMAcyt . After direct incubation of SMAcyt  with HVs or liposomes, samples were incubated with increasing Mg2+ concentration for 2 h, followed by centrifugation at 17000g for 15 min to pellet nonreconstituted SMAcyt . The supernatant containing HVs or liposomes was analyzed with SDS-PAGE (Coomassie Blue staining). Only subunit I of cyt bo3 is shown. The entire gel is shown in Figure S5. The activities of reconstituted cyt bo3 were compared by measuring the rates of oxygen consumption with the substrate ubiquinol 1 (Q1) (200 μM), which is reduced by dithiothreitol (DTT) (2 mM) (Figure A, see Supporting Information for details). Figure B shows the activity of SMAcyt  after reconstitution into either HVs or liposomes. In correspondence with the results above, LIP-SMAcyt  did not exhibit any substantial enzyme activity, in line with the fact that SMAcyt  does not reconstitute into liposomes. In contrast, HV-SMAcyt  shows clear activity, about half that of the control samples HV-DDMcyt  and LIP-DDMcyt  (Figure B). We note that, before reconstitution, the activity of the soluble SMAcyt  is significantly lower than the activity of DDMcyt  (Figure C–E). A reduction in activity has been previously reported for other enzymes in SMALPs.[50,51] The same reduction in activity is also apparent after DDMcyt  is reconstituted into liposomes (LIP-DDMcyt ). We speculate that this might be an experimental artifact due to differences in substrate access (Q1) to the quinol-binding site of the enzyme in DDM micelles vs the enzyme embedded into lipid membranes or SMALPs. Importantly, after resolubilization in 1% DDM detergent of both soluble SMAcyt  and HV-SMAcyt , cyt bo3 regains an activity similar to DDMcyt  (Figure E and F). This confirms that neither the solubilization of cyt bo3 into SMALPs nor the reconstitution into HVs irreversibly changes cyt bo3 and supports our hypothesis that the reduction in activity is due to the enzyme assay which utilizes a non-natural substrate analogue, Q1. This is further supported by a structure of cyt bo3 that was shown not to be affected by solubilization with a slightly different SMA copolymer (3:1).[31]
Figure 4

(A) Oxygen consumption trace for HV-SMAcyt . The oxygen consumption rate was determined via regression of the first 30 s from the slope and normalized by the protein concentration. (B) Comparison of the activities of reconstituted cyt bo3 determined via oxygen consumption. Error bars represent the standard deviation of three independent experiments. (C) Oxygen consumption traces for DDMcyt bo3 and (D) SMAcyt bo3. The traces show the activity before and after MgCl2 treatment. (E) Comparison of the activities of soluble SMAcyt bo3 and DDMcyt bo3 determined via oxygen consumption. The graph also shows the activity of soluble SMAcyt bo3 and HV-SMAcyt bo3 after resolubilization in DDM (1%). Error bars represent the standard deviation of three independent experiments. (F) Activity retention after incubation with 10 mM MgCl2 and centrifugation for the supernatant fractions of soluble DDMcyt bo3, soluble SMAcyt bo3, and soluble SMAcyt bo3 in the presence of 1% DDM. The activity retention was determined via comparison of the oxygen consumption rate (determined via regression of the first 30 s from the slope and normalized by the protein concentration) before and after MgCl2 treatment and centrifugation.

(A) Oxygen consumption trace for HV-SMAcyt . The oxygen consumption rate was determined via regression of the first 30 s from the slope and normalized by the protein concentration. (B) Comparison of the activities of reconstituted cyt bo3 determined via oxygen consumption. Error bars represent the standard deviation of three independent experiments. (C) Oxygen consumption traces for DDMcyt bo3 and (D) SMAcyt bo3. The traces show the activity before and after MgCl2 treatment. (E) Comparison of the activities of soluble SMAcyt bo3 and DDMcyt bo3 determined via oxygen consumption. The graph also shows the activity of soluble SMAcyt bo3 and HV-SMAcyt bo3 after resolubilization in DDM (1%). Error bars represent the standard deviation of three independent experiments. (F) Activity retention after incubation with 10 mM MgCl2 and centrifugation for the supernatant fractions of soluble DDMcyt bo3, soluble SMAcyt bo3, and soluble SMAcyt bo3 in the presence of 1% DDM. The activity retention was determined via comparison of the oxygen consumption rate (determined via regression of the first 30 s from the slope and normalized by the protein concentration) before and after MgCl2 treatment and centrifugation. In order to confirm that reconstituted cyt bo3 was fully inserted across the membranes of HVs, we evaluated the net change in intravesicular pH due to the proton-pumping activity of the enzyme upon chemical activation. Changes in internal pH were determined by ratiometric fluorescence measurements of the pH-sensitive fluorescent probe 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) (Figure S6, see Supporting Information for details). While HVs showed a constant intravesicular pH after the addition of DTT and Q1, both HV-SMAcyt  and HV-DDMcyt  displayed an increase of intravesicular pH (Figure A), similarly to LIP-DDMcyt  (Figure B). The increase in pH indicates that the cyt bo3 was successfully inserted into the membrane with a prevalence of an “outward” orientation, as previously demonstrated in liposomal reconstitution.[52,53]
Figure 5

Intravesicular pH change for (A) HVs, HV-SMAcyt , and HV-DDMcyt  and (B) liposomes and LIP-DDMcyt . Displayed curves are representatives of three independent experiments.

Intravesicular pH change for (A) HVs, HV-SMAcyt , and HV-DDMcyt  and (B) liposomes and LIP-DDMcyt . Displayed curves are representatives of three independent experiments. To further assess the ability of SMA to facilitate the reconstitution of membrane proteins (MPs) into HVs, we attempted the reconstitution of the full MPs composition of E. coli. To do this, an E. coli membrane extract (GO105/pJRhisA) was solubilized with SMA and nonsolubilized material removed by ultracentrifugation (100000g for 60 min). This full extract of all SMALPs was incubated with HVs on ice for 30 min, at a 2:8 protein mass to polymer and lipids mass ratio. MPs not reconstituted into HVs were again precipitated by addition of 10 mM MgCl2 and removed by centrifugation (17000g for 15 min). We compared the protein solubilization efficiencies of soluble and reconstituted MPs by measuring the protein concentration (bicinchoninic acid (BCA) assay, Table ). Overall, 52.6 (±4.6)% of the E. coli MPs were solubilized by SMA. After reconstitution, more than half of this fraction (29.4 (±6.8)%) was successfully reconstituted into HVs.
Table 2

Solubilization Efficiency of E. coli Membrane Protein Extract via SMALPs and subsequent reconstitution efficiency into HVsa

 SMALP fractionsolubilization efficiency (%)±SD
before MgCl2 additiontotal52.64.6
after MgCl2 and centrifugationsupernatant<1<1
pellet43.58.6
before MgCl2 additionHVs53.12.2
after MgCl2 and centrifugationHVs (supernatant)29.46.8
 HVs (pellet)21.65.3

Solubilization efficiency was determined by BCA assay and expressed as a percentage of total MP content prior to SMA solubilization.

Solubilization efficiency was determined by BCA assay and expressed as a percentage of total MP content prior to SMA solubilization. To assess whether the protein content after reconstitution into HVs was a true representation of the various MPs from native membranes of E. coli, we conducted an SDS-PAGE analysis for qualitative comparison (Figure A). SDS-PAGE showed very similar profiles for each condition, strongly suggesting that SMA can extract a wide range of membrane proteins and transfer these to HVs. This analysis also confirmed that precipitation of SMALPs with 10 mM MgCl2 (i.e., without HVs) removed the entire protein content if not reconstituted. Finally, we evaluated whether the MPs were functionally active after reconstituted into HVs by monitoring the activity of the cyt bo3, which was part of the MP extract mixture. Figure B and Figure S7 show the oxygen reduction activity of the full MP extracts solubilized by SMA before (SMAMPs) and after (HV-SMAMPs) reconstitution into HVs. The activity confirms that cyt bo3 was functionally active after transfer into HVs, indicating that complex mixtures of proteins can be reconstituted with SMA. The oxygen reduction activity, normalized against total MP content, is lower after reconstitution in HVs, and we hypothesize that this is due to different efficiencies of reconstitution of the various MPs.
Figure 6

(A) SDS-PAGE (15%) analysis of membrane protein samples contained in either SMAMPs or HV-SMAMPs before and after treatment with MgCl2 and separation of the insoluble part via precipitation. The concentration of E. coli membrane-protein fraction (MPs, lane 1) was halved in comparison to the other loaded samples to improve the quality of the SDS-PAGE. (B) Comparison of the oxygen-reducing activities of soluble SMAMPs, HV-SMAMPs, and SMA MPs treated with MgCl2 without HVs (“negative control”). The activity is normalized per mg of total MP content for SMAMPs and HV-SMAMPs determined via BCA assay. Error bars represent the standard deviation of three independent experiments.

(A) SDS-PAGE (15%) analysis of membrane protein samples contained in either SMAMPs or HV-SMAMPs before and after treatment with MgCl2 and separation of the insoluble part via precipitation. The concentration of E. coli membrane-protein fraction (MPs, lane 1) was halved in comparison to the other loaded samples to improve the quality of the SDS-PAGE. (B) Comparison of the oxygen-reducing activities of soluble SMAMPs, HV-SMAMPs, and SMA MPs treated with MgCl2 without HVs (“negative control”). The activity is normalized per mg of total MP content for SMAMPs and HV-SMAMPs determined via BCA assay. Error bars represent the standard deviation of three independent experiments.

Discussion and Conclusions

Although SMA-solubilized proteins have previously been shown to reconstitute into planar lipid bilayers[40] or liposomes,[41,42] the mechanisms by which this happens is not fully understood. Indeed, little is known about the interaction between SMALPs and lipid membranes, although it has been shown that the lipid packing properties and electrostatic interactions strongly influence how SMA interplays with the lipid bilayer.[54] Particularly, phospholipid phosphoethanolamine (PE), characterized by a negative intrinsic curvature,[55] exerts a lateral pressure that hampers SMA insertion and, therefore, membrane solubilization.[54,56,57] Similarly, we hypothesize that PE might hamper SMA reconstitution of MPs back into liposomes. This may explain the lack of reconstitution of SMAcyt  into the liposomes in this study, which were prepared from an E. coli “polar” lipid extract (PE, ∼65 mol %; PG, ∼25 mol %; and cardiolipin, ∼10 mol %).[15] We have previously observed that hybrid giant unilamellar vesicles (GUVs) of PBd22-b-PEO14 and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) are well-mixed and homogeneous with a similar molecular ordering and packing, but lower fluidity, than POPC lipid bilayers.[58] Previous works have also shown that the area stretching moduli (Ka) of polymersomes made of PBd-b-PEO polymers (90–130 mN/m[59,60]) are much lower than the typical Ka for phosphocholine liposomes (200–260 mN/m).[60,61] For HVs composed of PBd22-b-PEO14 and 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), or PBd46-b-PEO30 mixed with POPC, the area stretching modulus lies intermediate between that of pure polymer and pure lipid vesicles.[18,60] While comparable data are not available for mixtures of E. coli polar lipid extract and PBd22-b-PEO14, we infer that the block copolymer will impart a similar reduction in the stretching modulus of vesicles in this work. Importantly, the area stretching modulus is proportional to the surface tension (γ) of the membrane (Ka ∼4γ). The decreased surface tension and reduced work required to stretch the interface likely reduce the energy barrier for the transfer of cyt bo3 from the SMALPs to the HV membrane. It has previously been hypothesized that this enhanced elasticity of hybrid PBd22-b-PEO14 membranes lowers the energy cost for membrane deformations required to accommodate insertion of the membrane protein.[18] Thus, here, we consider the higher elasticity of the HV compared to liposomes to be essential for reconstitution of MPs from SMALPs. In conclusion, we show for the first time the reconstitution of SMA-solubilized membrane protein either as pure isolated protein (SMAcyt ) or as a complex MP mixture (SMAMPs), into vesicles without the use of detergents while maintaining protein activity. For cytochrome c oxidase, sonication or extrusion was required to induce its reconstitution into liposomes,[41] while for plasma membrane Na+/H+ antiporter, a much longer incubation time (overnight) with liposomes of larger diameter (400 nm) was needed and only ∼10% reconstitution was achieved.[42] In contrast, a simple incubation for 30 min on ice is sufficient to reconstitute SMAcyt  into HVs, while the same procedure does not lead to a transfer of cyt bo3 to liposomes. This method provides a new tool to reduce time and cost for enzyme reconstitution processes by avoiding detergent-mediated reconstitution and represents a solid foundation for further development as an enabling technology for MPs in nanomedicine, biocatalysis, and bottom-up synthetic biology.
  55 in total

1.  Membrane proteins solubilized intact in lipid containing nanoparticles bounded by styrene maleic acid copolymer.

Authors:  Timothy J Knowles; Rachael Finka; Corinne Smith; Yu-Pin Lin; Tim Dafforn; Michael Overduin
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

2.  Monitoring and modulating ion traffic in hybrid lipid/polymer vesicles.

Authors:  Walter F Paxton; Patrick T McAninch; Komandoor E Achyuthan; Sun Hae Ra Shin; Haley L Monteith
Journal:  Colloids Surf B Biointerfaces       Date:  2017-08-01       Impact factor: 5.268

Review 3.  Methods of reconstitution to investigate membrane protein function.

Authors:  Ruth Skrzypek; Shagufta Iqbal; Richard Callaghan
Journal:  Methods       Date:  2018-02-16       Impact factor: 3.608

Review 4.  Current problems and future avenues in proteoliposome research.

Authors:  Andrea Marco Amati; Simone Graf; Sabina Deutschmann; Nicolas Dolder; Christoph von Ballmoos
Journal:  Biochem Soc Trans       Date:  2020-08-28       Impact factor: 5.407

Review 5.  Polymer vesicles.

Authors:  Dennis E Discher; Adi Eisenberg
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

Review 6.  Mixed Hybrid Lipid/Polymer Vesicles as a Novel Membrane Platform.

Authors:  Matthias Schulz; Wolfgang H Binder
Journal:  Macromol Rapid Commun       Date:  2015-10-12       Impact factor: 5.734

7.  Membrane mixing and dynamics in hybrid POPC/poly(1,2-butadiene-block-ethylene oxide) (PBd-b-PEO) lipid/block co-polymer giant vesicles.

Authors:  Rashmi Seneviratne; Rosa Catania; Michael Rappolt; Lars J C Jeuken; Paul A Beales
Journal:  Soft Matter       Date:  2022-02-09       Impact factor: 3.679

8.  Constructing artificial respiratory chain in polymer compartments: Insights into the interplay between bo 3 oxidase and the membrane.

Authors:  Nika Marušič; Lado Otrin; Ziliang Zhao; Rafael B Lira; Fotis L Kyrilis; Farzad Hamdi; Panagiotis L Kastritis; Tanja Vidaković-Koch; Ivan Ivanov; Kai Sundmacher; Rumiana Dimova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

9.  A reconstitution method for integral membrane proteins in hybrid lipid-polymer vesicles for enhanced functional durability.

Authors:  Rashmi Seneviratne; Sanobar Khan; Ellen Moscrop; Michael Rappolt; Stephen P Muench; Lars J C Jeuken; Paul A Beales
Journal:  Methods       Date:  2018-02-02       Impact factor: 4.647

10.  Styrene maleic-acid lipid particles (SMALPs) into detergent or amphipols: An exchange protocol for membrane protein characterisation.

Authors:  Sophie J Hesketh; David P Klebl; Anna J Higgins; Maren Thomsen; Isabelle B Pickles; Frank Sobott; Asipu Sivaprasadarao; Vincent L G Postis; Stephen P Muench
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-01-13       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.